Fin Posillipo S.p.A.
Overview
Fin Posillipo is a holding company controlled by the Petrone Family that manages a diversified portfolio of investments. Founded in 1989, it has a strategic, long-term vision focused on pharmaceuticals, biotech, clean energy, and also invests in private equity and venture capital funds. It also operates as a financial and commercial consulting company within the pharmaceutical and healthcare sector.
Portfolio Companies
4
Website
finposillipo.itInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BetaGlue Therapeutics | Dec 2024 | VC Round | Co-investor |
| Pierrel S.p.A. | Jul 2023 | Follow-on Offering | Co-investor |
| 1000Farmacie | Apr 2020 | Seed | Co-investor |
| Altheia Science | Dec 2018 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Fin Posillipo S.p.A. based?
Fin Posillipo S.p.A. is headquartered in Italy.
When was Fin Posillipo S.p.A. founded?
Founding year information for Fin Posillipo S.p.A. is not publicly available.
How many portfolio companies does Fin Posillipo S.p.A. have?
Fin Posillipo S.p.A. has 4 portfolio companies in Caplight's dataset.
What are some companies in Fin Posillipo S.p.A.'s portfolio?
Recent investments visible on Caplight include BetaGlue Therapeutics, Pierrel S.p.A., BetaGlue Therapeutics, 1000Farmacie, Altheia Science.
What was Fin Posillipo S.p.A.'s most recent investment?
Fin Posillipo S.p.A.'s most recent investment on Caplight was in BetaGlue Therapeutics in 2024.
What sectors does Fin Posillipo S.p.A. focus on?
Fin Posillipo S.p.A. focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences.
What company stages does Fin Posillipo S.p.A. focus on?
Fin Posillipo S.p.A. typically invests at the MultiStage stage.